TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33845878

Group type: EXPERIMENTAL
Intervention: Functional and respiratory multidisciplinary rehabilitation protocol (6 days per week, 15 minutes, twice per day) during hospital stay and home exercises for 12 weeks post-discharge.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard of care (usual medical and nursing care in the ICU).
Number of subjects: 80
Study: 32892604

Group type: EXPERIMENTAL
Intervention: SGB group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 33422518

Group type: EXPERIMENTAL
Intervention: Radial access (RA)
Number of subjects: 2285

Group type: COMPARATOR
Intervention: Femoral access (FA)
Number of subjects: 2285
Study: 33355818

Group type: EXPERIMENTAL
Intervention: Post-Isometric Relaxation
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: LASER
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study: 34626075

Group type: EXPERIMENTAL
Intervention: Proposed test for comparing two binomial proportions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing methods (standard z-test and Jung's test)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed method
Number of subjects: 0
Study: 34758875

Group type: EXPERIMENTAL
Intervention: Stress management training program (8 sessions, 1.5 hours each, twice a week)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 35544650

Group type: EXPERIMENTAL
Intervention: Implementation strategies at community-based partner sites
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Investigator-initiated randomized therapeutic radiation trials in the MSK Alliance
Number of subjects: 84

Group type: COMPARATOR
Intervention: Matched trials open only at the main academic center
Number of subjects: 84
Study: 33267864

Group type: EXPERIMENTAL
Intervention: Extra marital affairs of partners
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Alcohol consumption by partners
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Time spent drawing water
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Overall prevalence of IPV
Number of subjects: 538
Study: 35611849

Group type: EXPERIMENTAL
Intervention: Complementary Spiritist Therapy (CST)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (routine maintenance)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: CST
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: CST (≥7 sessions)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: CST (2-3 sessions per week)
Number of subjects: 76
Study: 33419400

Group type: EXPERIMENTAL
Intervention: LA (lidocaine cream smeared to the cuff of the LMA before insertion, with mask removal in the awake state)
Number of subjects: 392

Group type: COMPARATOR
Intervention: LD (lidocaine application and LMA removal under deep anesthesia)
Number of subjects: 392

Group type: COMPARATOR
Intervention: NLA (hydrosoluble lubricant application and LMA removal in the awake state)
Number of subjects: 392

Group type: COMPARATOR
Intervention: NLD (hydrosoluble lubricant application and LMA removal in deep anesthesia)
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: LA
Number of subjects: 392

Group type: COMPARATOR
Intervention: LD
Number of subjects: 392

Group type: COMPARATOR
Intervention: NLA
Number of subjects: 392

Group type: COMPARATOR
Intervention: NLD
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: LA and NLA
Number of subjects: 392
Study: 32372458

Group type: EXPERIMENTAL
Intervention: Creams with nanoliposomes encapsulated with skimmed donkey milk
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Night cream with nanoliposomes encapsulated with skimmed donkey milk
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 15

Group type: COMPARATOR
Intervention: Untreated skin
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All treatments (Creams with donkey milk, Placebo cream, Untreated skin)
Number of subjects: 15
Study: 34787952

Group type: EXPERIMENTAL
Intervention: 25 g of d‐β‐hydroxybutyrate (βHB) in the form of a KE drink (ΔG®)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 25 g of d‐β‐hydroxybutyrate (βHB) in the form of a KE drink (ΔG®) with 2 g of L‐alanine
Number of subjects: 10
Study: 32798283

Group type: EXPERIMENTAL
Intervention: RSLV‐132 (10 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32674241

Group type: EXPERIMENTAL
Intervention: Food-based recommendations (FBR)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Non-Food-based recommendations (non-FBR)
Number of subjects: 102
Study: 33219136

Group type: EXPERIMENTAL
Intervention: Intensive treatment (systolic BP target of 110 to 139 mm Hg)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard treatment (systolic BP target of 140 to 179 mm Hg)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 1000
Study: 32705121

Group type: EXPERIMENTAL
Intervention: 12-session stress management intervention (n = 60)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care (n = 60)
Number of subjects: 120
Study: 34637055

Group type: EXPERIMENTAL
Intervention: Diode laser in addition to mechanical therapy (n=16)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser in addition to mechanical therapy (n=17)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional non-surgical mechanical therapy (Control group, n=17)
Number of subjects: 50
Study: 35323853

Group type: EXPERIMENTAL
Intervention: REACH intervention
Number of subjects: 88

Group type: COMPARATOR
Intervention: Education alone
Number of subjects: 88
Study: 34897211

Group type: EXPERIMENTAL
Intervention: Topical metronidazole ointment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Oral metronidazole
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 120
Study: 33667827

Group type: EXPERIMENTAL
Intervention: Living Through Psychosis (LTP) group programme
Number of subjects: 55
Study: 32496865

Group type: EXPERIMENTAL
Intervention: Awareness of community resources
Number of subjects: 950

Group type: EXPERIMENTAL
Intervention: Lethal risk factors
Number of subjects: 950

Group type: EXPERIMENTAL
Intervention: In-law encouragement of IPV
Number of subjects: 950

Group type: EXPERIMENTAL
Intervention: Supportive norms around community resource utilisation
Number of subjects: 950
Study: 34993754

Group type: EXPERIMENTAL
Intervention: Family Connects (FC)
Number of subjects: 994

Group type: COMPARATOR
Intervention: Natural comparison group (control)
Number of subjects: 994
Study: 32897570

Group type: EXPERIMENTAL
Intervention: Aprocitentan 10 mg/day for 9 days
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Aprocitentan 25 mg/day for 9 days
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Aprocitentan 50 mg/day for 9 days
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 35639602

Group type: EXPERIMENTAL
Intervention: TAK-003
Number of subjects: 14627

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14627
Study: 33630387

Group type: EXPERIMENTAL
Intervention: Tildrakizumab 100 mg
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Tildrakizumab 200 mg
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 33402627

Group type: EXPERIMENTAL
Intervention: Magnetized water
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.2% chlorhexidine
Number of subjects: 20
Study: 34569335

Group type: EXPERIMENTAL
Intervention: 1 week of plaster cast
Number of subjects: 40

Group type: COMPARATOR
Intervention: 4 to 5 weeks of plaster cast
Number of subjects: 40
Study: 36137949

Group type: EXPERIMENTAL
Intervention: 20 Hz rTMS treatment of the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 46
Study: 33789429

Group type: EXPERIMENTAL
Intervention: Shoulder external rotation strength training program (2 exercises, 3 times per week for 8 weeks)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 92
Study: 32525715

Group type: EXPERIMENTAL
Intervention: Outcome-adaptive randomization
Number of subjects: 0
Study: 34387891

Group type: EXPERIMENTAL
Intervention: United States written rules for environmental risk regulation
Number of subjects: 45

Group type: COMPARATOR
Intervention: China's written rules for environmental risk regulation
Number of subjects: 45
Study: 35081915

Group type: EXPERIMENTAL
Intervention: Alternative method (elevating the arm to 90° for 10 seconds after 6 mg of adenosine)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard method (double syringe technique of 6 mg of adenosine)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both groups (alternative and standard methods)
Number of subjects: 30
Study: 34153022

Group type: EXPERIMENTAL
Intervention: NPWT with TCDO instillation (NPWTi)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard NPWT
Number of subjects: 48
Study: 32814313

Group type: EXPERIMENTAL
Intervention: ICD‐10 codes for cirrhosis diagnosis
Number of subjects: 3396
Study: 34418302

Group type: EXPERIMENTAL
Intervention: Resorbable glass microfiber matrix (Mirragen; Advanced Wound Matrix [BBGFM])
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard of care (SOC, collagen alginate dressing)
Number of subjects: 40
Study: 32861369

Group type: EXPERIMENTAL
Intervention: Goniometer-Pro android app
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Intra-rater reliability
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Inter-rater reliability
Number of subjects: 71
Study: 36161276

Group type: EXPERIMENTAL
Intervention: Preincisional intravenous paracetamol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Postincisional intravenous paracetamol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 33847022

Group type: EXPERIMENTAL
Intervention: Tunnel technique with subepithelial connective tissue graft (TUN+CTG)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Coronally advanced flap with enamel matrix derivate (CAF+EMD)
Number of subjects: 18
Study: 33020101

Group type: EXPERIMENTAL
Intervention: Non-invasive oscillating device (NIOD) at 40 Hz
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Non-invasive oscillating device (NIOD) at 60 Hz
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Non-invasive oscillating device (NIOD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chest physiotherapy (CPT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Non-invasive oscillating device (NIOD) and CPT
Number of subjects: 60
Study: 34785763

Group type: EXPERIMENTAL
Intervention: Vigil immunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35690181

Group type: EXPERIMENTAL
Intervention: Caffeine 50 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Caffeine 250 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: d9-caffeine (molar-equivalent dose)
Number of subjects: 20
Study: 32580698

Group type: EXPERIMENTAL
Intervention: Stepped-wedge trial with unequal cluster sizes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment‐vs‐time period correlation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Absolute treatment group imbalance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomization algorithm
Number of subjects: 0
Study: 36447198

Group type: EXPERIMENTAL
Intervention: Hypnosis session with self-hypnosis posthypnotic suggestions
Number of subjects: 169

Group type: COMPARATOR
Intervention: Conversational interview with the hypnotherapist (Control)
Number of subjects: 169
Study: 33663659

Group type: COMPARATOR
Intervention: Saline + 5 mg tropisetron (Group A)
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: 40 mg methylprednisolone sodium succinate + 5 mg tropisetron (Group B)
Number of subjects: 485
Study: 35616597

Group type: COMPARATOR
Intervention: Modified osoto-gari defence reaction
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Common osoto-gari defence reaction
Number of subjects: 26
Study: 35896895

Group type: EXPERIMENTAL
Intervention: Biodegradable polymer-coated everolimus-eluting stents (BP-EES)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Durable polymer-coated everolimus-eluting stents (DP-EES)
Number of subjects: 120
Study: 34076230

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D (25(OH)D) levels in DVT group
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D (25(OH)D) levels in females of DVT group
Number of subjects: 280

Group type: COMPARATOR
Intervention: Serum 25-hydroxyvitamin D (25(OH)D) levels in control group
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Logistic regression analysis of 25(OH)D
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Weight, height, and body mass index
Number of subjects: 280
Study: 33539582

Group type: EXPERIMENTAL
Intervention: Active network-tDCS
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study: 32363608

Group type: EXPERIMENTAL
Intervention: Meaningful and Enjoyable Activities Scale (MEAS)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Functional independence
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Revised three-factor 9-item model
Number of subjects: 63
Study: 36160382

Group type: EXPERIMENTAL
Intervention: Clopidogrel alone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clopidogrel + ilaprazole
Number of subjects: 40
Study: 36383391

Group type: EXPERIMENTAL
Intervention: Omega-3
Number of subjects: 535

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 535
Study: 32305093

Group type: EXPERIMENTAL
Intervention: Acalabrutinib with obinutuzumab
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Acalabrutinib monotherapy
Number of subjects: 535

Group type: COMPARATOR
Intervention: Obinutuzumab-chlorambucil
Number of subjects: 535
Study: 616026493

Group type: EXPERIMENTAL
Intervention: BBFC + PGA (Brinzolamide 1%/Brimonidine 0.2%)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Vehicle + PGA
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: BBFC + TRAVATAN Z
Number of subjects: 182

Group type: COMPARATOR
Intervention: Vehicle + TRAVATAN Z
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: BBFC + XALATAN
Number of subjects: 182

Group type: COMPARATOR
Intervention: Vehicle + XALATAN
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: BBFC + LUMIGAN
Number of subjects: 182

Group type: COMPARATOR
Intervention: Vehicle + LUMIGAN
Number of subjects: 182
Study: 35413923

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA intensity for 20 min)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 64
Study: 34619933

Group type: EXPERIMENTAL
Intervention: Clinical pharmacist's assessment of bleeding risk and targeted medication education using warfarin medication checklist at discharge
Number of subjects: 147

Group type: COMPARATOR
Intervention: Routine warfarin medication education at discharge
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Warfarin medication checklist
Number of subjects: 147
Study: 32807252

Group type: EXPERIMENTAL
Intervention: Whey protein isolate (WP) supplementation, 20 g twice a day for 15 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Casein (CA) supplementation, 20 g twice a day for 15 days
Number of subjects: 0
Study: 35330408

Group type: EXPERIMENTAL
Intervention: PENG block
Number of subjects: 58

Group type: COMPARATOR
Intervention: FICB
Number of subjects: 58
Study: 33577995

Group type: EXPERIMENTAL
Intervention: n-back task (3-back)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 0-back task
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: n-back task (2-back)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 0-back and n-back tasks
Number of subjects: 38
Study: 32293967

Group type: EXPERIMENTAL
Intervention: Vocal function exercises (VFEs) + vocal hygiene
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vocal hygiene only
Number of subjects: 40
Study: 36509982

Group type: EXPERIMENTAL
Intervention: Aerobic training (AT) intervention group (MS-AT)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Motor training control group (MS-C)
Number of subjects: 61
Study: 33200245

Group type: EXPERIMENTAL
Intervention: ACB combined with LFCNB
Number of subjects: 160

Group type: COMPARATOR
Intervention: PIA
Number of subjects: 160
Study: 32248934

Group type: EXPERIMENTAL
Intervention: Best possible self or gratitude journal writing intervention (6 weeks, at least 3 entries per week)
Number of subjects: 34
Study: 36113576

Group type: EXPERIMENTAL
Intervention: Group prenatal care
Number of subjects: 2350

Group type: EXPERIMENTAL
Intervention: Group prenatal care (Black participants)
Number of subjects: 2350

Group type: COMPARATOR
Intervention: Individual prenatal care (Black participants)
Number of subjects: 2350
Study: 33188769

Group type: EXPERIMENTAL
Intervention: Topical administration of tranexamic acid
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intravenous administration of tranexamic acid
Number of subjects: 90
Study: 32026352

Group type: EXPERIMENTAL
Intervention: Pharmacist interventional model (disease education, dietary recommendations, counseling, telephonic follow-up)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pharmacist interventional model
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pharmacist interventional model and Control group
Number of subjects: 120
Study: 35813842

Group type: EXPERIMENTAL
Intervention: Royal jelly (400 mg) plus coenzyme Q10 (60 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 34091663

Group type: EXPERIMENTAL
Intervention: Diets rich in long-chain n-3 fatty acids (LCn3)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Diets rich in polyphenols (PP)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Whole-grain cereals (WGC)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Refined Cereal group
Number of subjects: 126
Study: 35500840

Group type: EXPERIMENTAL
Intervention: LSD
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: d-amphetamine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: MDMA
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 32356212

Group type: EXPERIMENTAL
Intervention: Diode laser treatment (G1)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Electrocautery treatment (G2)
Number of subjects: 36
Study: 35979802

Group type: EXPERIMENTAL
Intervention: Hughes closure (double far‐near‐near‐far sutures of 1 nylon suture at 2‐cm intervals along the fascia combined with conventional mass closure)
Number of subjects: 802

Group type: COMPARATOR
Intervention: Standard mass closure
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Hughes closure
Number of subjects: 802
Study: 36326668

Group type: EXPERIMENTAL
Intervention: Fast Track intervention
Number of subjects: 891

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 891
Study: 33398511

Group type: EXPERIMENTAL
Intervention: Longer interval group (> 10 weeks)
Number of subjects: 910

Group type: COMPARATOR
Intervention: Shorter interval group (≤ 10 weeks)
Number of subjects: 910

Group type: EXPERIMENTAL
Intervention: Cox multivariate regression analysis
Number of subjects: 910
Study: 32957394

Group type: EXPERIMENTAL
Intervention: Conservative fluid management strategy
Number of subjects: 956

Group type: COMPARATOR
Intervention: Liberal fluid management strategy
Number of subjects: 956
Study: 32994540

Group type: EXPERIMENTAL
Intervention: Wet hands
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Dry hands
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Sunscreen hands
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Overall (across all conditions)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Girls
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Pressure of contact
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Average adhered sand grain size and average ambient sand grain size
Number of subjects: 122
Study: 32506859

Group type: EXPERIMENTAL
Intervention: Honey mouthwash 12.5%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chlorhexidine solution 0.2%
Number of subjects: 60
Study: 36450107

Group type: EXPERIMENTAL
Intervention: 0.08% nanoemulsion cyclosporine A (TJO‐087) once daily
Number of subjects: 178

Group type: COMPARATOR
Intervention: 0.05% emulsion cyclosporine A (CsA0.05%) twice daily
Number of subjects: 178
Study: 34181564

Group type: EXPERIMENTAL
Intervention: Interval training (2 × 4 × 200-m)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Race-pace continuous workout (600-m)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both workouts
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Interval training
Number of subjects: 19
Study: 33290405

Group type: EXPERIMENTAL
Intervention: Obesity duration <5 years
Number of subjects: 20746

Group type: EXPERIMENTAL
Intervention: Obesity duration 20 to 30 years
Number of subjects: 20746

Group type: EXPERIMENTAL
Intervention: Obesity duration
Number of subjects: 20746
Study: 34739064

Group type: EXPERIMENTAL
Intervention: Universal screening (all students completed the Patient Health Questionnaire‐9 (PHQ‐9))
Number of subjects: 12909

Group type: EXPERIMENTAL
Intervention: Universal screening
Number of subjects: 12909

Group type: COMPARATOR
Intervention: Targeted screening
Number of subjects: 12909
Study: 32078064

Group type: EXPERIMENTAL
Intervention: Selenium and coenzyme Q10 supplementation
Number of subjects: 308
Study: 32576559

Group type: EXPERIMENTAL
Intervention: SSc-ILD
Number of subjects: 86

Group type: COMPARATOR
Intervention: IPF
Number of subjects: 86
Study: 35312782

Group type: EXPERIMENTAL
Intervention: Open harvesting
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: External stenting in open-harvest group
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: External stenting in endoscopic-harvest group
Number of subjects: 183
Study: 32300654

Group type: EXPERIMENTAL
Intervention: Measurement protocols to reveal many-body topological invariants using local random unitary operations and site-resolved projective measurements.
Number of subjects: 0